Clinical findings and gingival crevicular fluid prostaglandin E2 and interleukin-1-beta levels following initial periodontal treatment and short-term meloxicam administration

Bibliography

• Jeffcoat MK, Williams KC, Reddy MS, Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodontal Res 1988;23:381-5
   PubMed Web of Science ®Google Scholar
• Reddy MS, Palcanis KG, Barnett ML, Efficacy of meclofenomate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 1993;20:635-40
   PubMedGoogle Scholar
• Xie W, Chipman JG, Robertson DL, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by RNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6
   PubMed Web of Science ®Google Scholar
• Vane JR. Towards a better aspirin. Nature 1994;367:215-16
   PubMed Web of Science ®Google Scholar
• Engelhardt G. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 1996;35(Suppl 1):4-12
   PubMedGoogle Scholar
• Bezerra MM, Lima V, Alencar VBM, Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000;71:1009-14
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Pelletier JM. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoartritic cartilage. Drugs 1993;46(Suppl 1):34-9
   PubMedGoogle Scholar
• Buduneli N, Vardar S, Atilla G, Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 2002;73:103-9
   PubMedGoogle Scholar
• Çetin EÖ, Buduneli N, Atlihan E, Kirilmaz L. In vitro studies of a degradable device for controlled-release of meloxicam. J Clin Periodontol 2005;32:773-7
   PubMed Web of Science ®Google Scholar
• Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996;1:879-925
   PubMedGoogle Scholar
• Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-44
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Odle BM, Braswell LD, Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. J Periodont Res 1989;24:63-74
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Wolf SM. The role of interleukin-1 in disease. N Engl J Med 1993;14:106-13
   Google Scholar
• Vardar S, Buduneli E, Baylas H, Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats. J Periodontol 2005;76:99-106
   PubMedGoogle Scholar
• Vardar-Şengül S, Buduneli N, Buduneli E, Effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats. J Periodontol 2006;77:657-63
   Google Scholar
• Vardar-Şengül S, Buduneli E, Türkoǧlu O, The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2 chain immunolocalization in experimental periodontitis. J Periodontol 2008;79:1934-41
   PubMedGoogle Scholar
• Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6
   PubMedGoogle Scholar
• Saxer UP, Mühleman HR. Motivation and instruction [in German]. Sch MZZ 1975;85:905-19
   Google Scholar
• Badersten A, Nilveus R, Egelberg J. Effect of non-surgical periodontal therapy. (IV) Operator variability. J Clin Periodontol 1985;12:723-9
   Google Scholar
• Buduneli N, Kütükçüler N, Aksu G, Atilla G. Evaluation of transforming growth factor-beta1 level in crevicular fluid of cyclosporine A-treated patients. J Periodontol 2001;72:526-31
   PubMedGoogle Scholar
• Hotz G. Medical treatment of postoperative and posttraumatic swellings [in German]. ZWR 1986;95:256-61
   PubMedGoogle Scholar
• Lamster IB, Hartley LJ, Oshrain RL. Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips. Arch Oral Biol 1985;30:235-42
   PubMedGoogle Scholar
• Lamster IB, Oshrain RL, Gordon JM. Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 1986;13:799-804
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Farr DH, Goodson JM. Measurement of prostaglandin E in gingival crevicular fluid. J Clin Periodontol 1981;8:359-67
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodont Res 1984;19:1-13
   PubMedGoogle Scholar
• Söder B. Neutrophil elastase activity, levels of prostaglandin E2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and non-smokers. Acta Odontol Scand 1999;57:77-82
   PubMed Web of Science ®Google Scholar
• Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998;47(Suppl 2):S78-87
   Google Scholar
• Toker H, Marakoǧlu I, Poyraz Ö. Effect of meloxicam on gingival crevicular fluid IL-1beta and IL1 receptor antagonist levels in subjects with chronic periodontitis, and its effects on clinical parameters. Clin Oral Investig 2006;10:305-10
   PubMedGoogle Scholar
• Azoubel MCF, Sarmento VA, Cangussu V, Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation. J Periodontol 2008;79:1719-25
   PubMedGoogle Scholar
• Yen CA, Damoulis PD, Stark PC, The effect of a selective cyclooxygenase-2 inhibitor (Celecoxib) on chronic periodontitis. J Periodontol 2008;79:104-13
   PubMedGoogle Scholar
• Oliveira TM, Sakai VT, Machado MA, COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats. J Periodontol 2008;79:1062-9
   PubMedGoogle Scholar
• Greenwald RA, Moak SA, Ramamurthy NS, Golub LM. Tetracyclines supress MMP activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992;19:927-38
   PubMed Web of Science ®Google Scholar
• Ciancio SG. Non-surgical periodontal treatment. In: Nevins M, Becker W, Kornman K, editors, Proceedings of the World Workshop in Clinical Periodontics. American Academy of Periodontology, Chicago; 1989. pp. II-4
   Google Scholar
• Cannon CP, Curtis SP, Bolognese JA, Laine L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. Am Heart J 2006;152:237-45
   PubMed Web of Science ®Google Scholar
• Queiroz-Junior CM, Pacheco CMF, Maltos KLM, Role of systemic and local administration of selective inhibitors of cyclooxygenase 1 and 2 in an experimental model of periodontal disease in rats. J Periodont Res 2009;44:153-60
   PubMedGoogle Scholar
• Vardar S, Baylas H, Huseyinov A. Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and F2alpha and clinical parameters of chronic periodontitis. J Periodontol 2003;74:57-63
   PubMedGoogle Scholar